Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
First Affiliated Hospital of Guangzhou Medical University · State Key Laboratory of Respiratory Disease · +24 more institutions
Abstract
The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly worldwide.
To evaluate the risk of serious adverse outcomes in patients with COVID-19 by stratifying the comorbidity status.
Citation impact
- FWCI
- 89.83
- Percentile
- 100%
- References
- 36
Authors
47- WGWei-Jie GuanCorresponding
First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University
- WLWenhua Liang
First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University
- YZYi Zhao
First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University
- HLHeng-rui Liang
First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University
- ZCZi‐Sheng Chen
Third Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Guangzhou Medical University, Sanya Central Hospital, State Key Laboratory of Respiratory Disease, Guangzhou Medical University
Topics & keywords
- Medicine
- Comorbidity
- Internal medicine
- Diabetes mellitus
- Intensive care unit
- Coronavirus disease 2019 (COVID-19)
- Population
- COPD
- No poverty